Business / Finance

RSS

Bristol-Myers Squibb enters strategic partnership with WuXi Pharmatech

Bristol-Myers Squibb Company (NYSE: BMY) and WuXi PharmaTech (NYSE: WX) today announced that they have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to support global marketing applications.

8 Mar 2011

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor Pharmaceuticals (NASDAQ:ANAC) and the Institute for OneWorld Health (iOWH) today announced the establishment of a joint research agreement to discover antibacterial compounds for treating shigellosis.

8 Mar 2011

RadNet fourth quarter revenues increase 10.2% to $13.5 million

RadNet, a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 201 owned and/or operated outpatient imaging centers, today reported financial results for its fourth quarter and full year ended December 31, 2010.

8 Mar 2011

George Brown College works with MEMOTEXT for developing new patient adherence program

George Brown College is collaborating with MEMOTEXT, a patient adherence and medication compliance company, to develop an inference-based telephone/short message service (SMS) based communications program for an overseas health stakeholder-based research project.

8 Mar 2011

Fresenius Medical Care announces acquisition of Hema Metrics assets related to Crit-Line system

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced the acquisition of all assets of Hema Metrics LLC related to its Crit-Line system.

8 Mar 2011

Sectra’s third quarter net sales increase 13.9% to SEK 229.1 million

IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.

8 Mar 2011

Humana joins with iCan to offer new individual healthcare plans

Humana Inc. (NYSE: HUM) has teamed with the iCan Benefit Group to offer a new line of discounted products for individual consumers. Effective immediately, people can access a variety of discounted packages that include dental, vision and pharmacy products.

8 Mar 2011

Aerie Pharmaceuticals closes $30 million Series B financing

Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing.

7 Mar 2011

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

7 Mar 2011

RadNet executes definitive agreement to acquire imaging centers in Maryland

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 201 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire five multi-modality imaging centers in Maryland from Diagnostic Health Corporation for an undisclosed combination of cash and the assumption of certain liabilities.

7 Mar 2011

Mangrove Partners comments that its analysis inaccurately portrayed in CPEX's letter to stockholders

Mangrove Partners, owners of 149,373 shares representing approximately 5.71% of the outstanding shares of CPEX Pharmaceuticals, Inc, believes its analysis and intentions were inaccurately portrayed in CPEX's March 2, 2011 letter to stockholders, which appears to use scare tactics in order to pressure stockholders into accepting an inadequate price for their shares.

5 Mar 2011

Angiotech extends offer to exchange new senior floating rate notes for Existing Floating Rate Notes

Angiotech Pharmaceuticals, Inc. today announced that it has extended its offer to exchange new senior floating rate notes due 2013 for all of its outstanding Senior Floating Rate Notes due 2013 to 11:59 p.m. New York City time on March 30, 2011.

5 Mar 2011

Advaxis CEO issues statement to shareholders regarding recent common stock transition

Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:

5 Mar 2011

BATSK advances 0.3% stock this week in the U.S.

BATS Global Markets, a global stock market operator, reports the BATS 1000 Index advanced 0.3% for the week ending March 4 in the U.S. The S&P 500 Index was up 0.1% for the same period.

5 Mar 2011

MedQuist extends exchange offer for all outstanding shares of common stock

MedQuist Holdings Inc., a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, today announced that it has extended the expiration date for its exchange offer for all issued and outstanding shares of MedQuist Inc. common stock until 5:00 p.m., New York City time, on Friday, March 11, 2011, unless further extended or earlier terminated.

5 Mar 2011

Agenus receives letter from Listing Qualifications Staff of The NASDAQ Stock Market

Agenus Inc. announced today that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC on March 3, 2011 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.

5 Mar 2011

Shares of Bacterin's common stock receive approval for listing on NYSE Amex

Bacterin International Holdings, Inc., a creator and developer of revolutionary bone graft material and anti-infective coatings for medical applications, today announced that its common stock has been approved for listing on the NYSE Amex and has chosen Knight Capital Group as its designated market maker.

5 Mar 2011

Pending merger transaction between Grifols, Talecris has been extended

Grifols S.A. and Talecris Biotherapeutics Holdings Corp. today announced that the outside date under their merger agreement for closing their pending merger transaction has been extended to June 30, 2011 (from March 6, 2011).

5 Mar 2011

Biosante to purchase $25.1 million shares of common stock in registered direct offering

BioSante Pharmaceuticals, Inc. today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering.

5 Mar 2011

Skilled Healthcare Group to transfer operations of five indirect subsidiaries to Brius Healthcare

Skilled Healthcare Group, Inc. today announced that five of its indirect subsidiaries that operate skilled nursing facilities in northern California have entered into an agreement to transfer their operations to Brius Healthcare, LLC and expects the transfer to be completed in April 2011 following the receipt of necessary regulatory approvals.

5 Mar 2011

Business / Finance

Bristol-Myers Squibb enters strategic partnership with WuXi Pharmatech

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

RadNet fourth quarter revenues increase 10.2% to $13.5 million

George Brown College works with MEMOTEXT for developing new patient adherence program

Fresenius Medical Care announces acquisition of Hema Metrics assets related to Crit-Line system

Sectra’s third quarter net sales increase 13.9% to SEK 229.1 million

Humana joins with iCan to offer new individual healthcare plans

Aerie Pharmaceuticals closes $30 million Series B financing

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

RadNet executes definitive agreement to acquire imaging centers in Maryland

Mangrove Partners comments that its analysis inaccurately portrayed in CPEX's letter to stockholders

Angiotech extends offer to exchange new senior floating rate notes for Existing Floating Rate Notes

Advaxis CEO issues statement to shareholders regarding recent common stock transition

BATSK advances 0.3% stock this week in the U.S.

MedQuist extends exchange offer for all outstanding shares of common stock

Agenus receives letter from Listing Qualifications Staff of The NASDAQ Stock Market

Shares of Bacterin's common stock receive approval for listing on NYSE Amex

Pending merger transaction between Grifols, Talecris has been extended

Biosante to purchase $25.1 million shares of common stock in registered direct offering

Skilled Healthcare Group to transfer operations of five indirect subsidiaries to Brius Healthcare

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News